Ahmet Ozturk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmet Ozturk has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Sinan Sari
Department of Orthopedics and Traumatology, Konya City Hospital, Konya, Türkiye
1 shared publication - Aysen Terzi
Department of Pathology, Baskent University, Ankara, Turkey
1 shared publication - Candan Altuntaş
Department of Stem Cell, Institute of Health Sciences, Kocaeli University, 41001 Kocaeli, Türkiye
1 shared publication - Emre Demi̇rÇay1 shared publication
- Erdal Karaoz
Liv Hospital Ulus, Regenerative Medicine and Stem Cell Center, Istanbul, Turkey
1 shared publication - Erkut Attar
Department of Obstetrics & Gynaecologist Yeditepe University, Faculty of Medicine, Reproductive Endocrinology Unit Istanbul Turkey
1 shared publication
Latest Publications
- Open Access
- 27 October 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-16
Quercetin-loaded mesenchymal stem cell derived extracellular vesicles enhance ovarian function in a cyclophosphamide induced ovarian damage
Background: To investigate whether intraovarian administration of quercetin-loaded extracellular vesicles derived from Wharton’s jelly mesenchymal stem cells (EVs-QUE) improves ovarian function in a cyclophosphamide (CTX)-induced premature ovarian insufficiency (POI) rat model. Methods: Human Wharton’s jelly-derived mesenchymal stem cells (MSCs) were cultured, and extracellular vesicles (EVs) were isolated and characterized by flow cytometry and electron microscopy. Quercetin was loaded onto EVs using ultrasonic incubation to generate EVs-QUE. A rat model of CTX-induced POI was established, and the subjects received intraovarian injections of either EVs or EVs-QUE. Ovarian function was assessed through histological evaluation, immunofluorescence staining, and gene expression analysis. Results: Treatment with EVs-QUE significantly improved ovarian morphology and folliculogenesis, reduced the number of atretic follicles, and decreased Casp3 expression. Proliferation markers ( Ki67 , Pcna ) and antioxidant genes ( Nrf2 , Sod1 ) were upregulated. Additionally, steroidogenesis- and oocyte-related genes ( Star , Gdf9 , Bmp15 ) showed increased expression. Although systemic hormonal alterations were limited, local tissue analysis confirmed a regenerative effect in the EVs-QUE group. Conclusions: Quercetin-loaded EVs derived from Wharton’s jelly MSCs enhanced ovarian recovery in a CTX-induced POI model through anti-apoptotic, pro-proliferative, and antioxidant pathways. These findings suggest that intraovarian administration of EVs-QUE may represent a promising strategy for fertility preservation and warrant further investigation in long-term and translational studies.
- 27 October 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-16
Open AccessQuercetin-loaded mesenchymal stem cell derived extracellular vesicles enhance ovarian function in a cyclophosphamide induced ovarian damage
Background: To investigate whether intraovarian administration of quercetin-loaded extracellular vesicles derived from Wharton’s jelly mesenchymal stem cells (EVs-QUE) improves ovarian function in a cyclophosphamide (CTX)-induced premature ovarian insufficiency (POI) rat model. Methods: Human Wharton’s jelly-derived mesenchymal stem cells (MSCs) were cultured, and extracellular vesicles (EVs) were isolated and characterized by flow cytometry and electron microscopy. Quercetin was loaded onto EVs using ultrasonic incubation to generate EVs-QUE. A rat model of CTX-induced POI was established, and the subjects received intraovarian injections of either EVs or EVs-QUE. Ovarian function was assessed through histological evaluation, immunofluorescence staining, and gene expression analysis. Results: Treatment with EVs-QUE significantly improved ovarian morphology and folliculogenesis, reduced the number of atretic follicles, and decreased Casp3 expression. Proliferation markers ( Ki67 , Pcna ) and antioxidant genes ( Nrf2 , Sod1 ) were upregulated. Additionally, steroidogenesis- and oocyte-related genes ( Star , Gdf9 , Bmp15 ) showed increased expression. Although systemic hormonal alterations were limited, local tissue analysis confirmed a regenerative effect in the EVs-QUE group. Conclusions: Quercetin-loaded EVs derived from Wharton’s jelly MSCs enhanced ovarian recovery in a CTX-induced POI model through anti-apoptotic, pro-proliferative, and antioxidant pathways. These findings suggest that intraovarian administration of EVs-QUE may represent a promising strategy for fertility preservation and warrant further investigation in long-term and translational studies.
- Open Access
- 23 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF BIOLOGY
- Vol. 45 (3) , 301-313
The promising effects of BMP2 transfected mesenchymal stem cells on human osteosarcoma
Selective targeting of transfected mesenchymal stem cells (MSCs) carrying specific antioncogenes to the tumor was suggested as a treatment option. Bone morphogenetic protein-2 (BMP2) was shown to inhibit the proliferation and aggressiveness of osteosarcoma (OS) cells. Here, we aimed to assess the homing efficiency of intraperitoneally administered hMSCs transfected with BMP2 to the tumoral site and their effects on OS using an orthotopic xenograft murine model. Orthotopic xenograft murine model of OS in six-week-old female NOD/SCID mice using 143B cells was established. hMSCs transfected with BMP2 (BMP2(+)hMSC) were used. In vivo experiments performed on four groups of mice that received no treatment, or intraperitoneally administered BMP2, hMSCs, and BMP2(+)hMSCs. Histopathological and immunohistochemical studies were used to evaluate the pathological identification and to assess the dimensions and necrotic foci of the tumor, the features of lung metastases, and immunostaining against p27, Ki-67, and caspase-3 antibodies. The osteogenic differentiation markers BMP2, BMP4, COL1A1, OPN, OCN and PF4 evaluated using RT-PCR. The tumor dimensions in the hMSCs group were significantly higher than those of the remaining groups (p < 0.01). The number of metastatic foci in the BMP2(+)hMSCs group was significantly lower than those of the other groups (p < 0.01). The current results showed that the intraperitoneal route could be efficiently used for targeting hMSCs to the tumoral tissues for effective BMP2 delivery. In this study, the effects of BMP2 transfected hMSCs on human OS and metastasis were promising for achieving osteogenic differentiation and reduced metastatic process.
- 23 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF BIOLOGY
- Vol. 45 (3) , 301-313
Open AccessThe promising effects of BMP2 transfected mesenchymal stem cells on human osteosarcoma
Selective targeting of transfected mesenchymal stem cells (MSCs) carrying specific antioncogenes to the tumor was suggested as a treatment option. Bone morphogenetic protein-2 (BMP2) was shown to inhibit the proliferation and aggressiveness of osteosarcoma (OS) cells. Here, we aimed to assess the homing efficiency of intraperitoneally administered hMSCs transfected with BMP2 to the tumoral site and their effects on OS using an orthotopic xenograft murine model. Orthotopic xenograft murine model of OS in six-week-old female NOD/SCID mice using 143B cells was established. hMSCs transfected with BMP2 (BMP2(+)hMSC) were used. In vivo experiments performed on four groups of mice that received no treatment, or intraperitoneally administered BMP2, hMSCs, and BMP2(+)hMSCs. Histopathological and immunohistochemical studies were used to evaluate the pathological identification and to assess the dimensions and necrotic foci of the tumor, the features of lung metastases, and immunostaining against p27, Ki-67, and caspase-3 antibodies. The osteogenic differentiation markers BMP2, BMP4, COL1A1, OPN, OCN and PF4 evaluated using RT-PCR. The tumor dimensions in the hMSCs group were significantly higher than those of the remaining groups (p < 0.01). The number of metastatic foci in the BMP2(+)hMSCs group was significantly lower than those of the other groups (p < 0.01). The current results showed that the intraperitoneal route could be efficiently used for targeting hMSCs to the tumoral tissues for effective BMP2 delivery. In this study, the effects of BMP2 transfected hMSCs on human OS and metastasis were promising for achieving osteogenic differentiation and reduced metastatic process.